Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,989 | 35,627 | 66,886 | 130,101 | 122,162 |
| Marketable Securities | 62,876 | 135,930 | 176,636 | 47,504 | 72,075 |
| TOTAL | $122,252 | $178,306 | $246,615 | $180,329 | $198,661 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 165 | 36 |
| Investments And Advances | 0 | 59,968 | 62,553 | 15,837 | 31,619 |
| Other Non-Current Assets | 581 | 718 | 957 | 256 | 14 |
| TOTAL | $581 | $60,686 | $63,510 | $16,258 | $31,669 |
| Total Assets | $122,833 | $238,992 | $310,125 | $196,587 | $230,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,765 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 554 | 5,648 | 1,379 | 1,640 | 1,088 |
| Accrued Expenses | 20,688 | 21,959 | 10,836 | 6,067 | 4,059 |
| TOTAL | $30,007 | $27,607 | $12,971 | $7,812 | $5,147 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,396 | 29,419 | 29,897 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 150 | 284 | 0 | 0 |
| TOTAL | $22,396 | $29,569 | $30,181 | $N/A | $N/A |
| Total Liabilities | $52,403 | $57,176 | $43,152 | $7,812 | $5,147 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,213 | 60,573 | 60,080 | 41,025 | 40,473 |
| Common Shares | 6 | 6 | 6 | 4 | 4 |
| Retained earnings | -446,462 | -325,127 | -222,798 | -170,427 | -127,571 |
| Other shareholders' equity | 83 | -48 | 312 | -751 | -231 |
| TOTAL | $70,430 | $181,816 | $266,973 | $188,775 | $225,183 |
| Total Liabilities And Equity | $122,833 | $238,992 | $310,125 | $196,587 | $230,330 |